# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

A. 510(k) Number: k051517   
B. Purpose for Submission: New device   
C. Measurand: Quality Control Material (assayed for Ferritin, Folate, and Vitamin B12)   
D. Type of Test: Quality Control Materials for Ferritin, Folate, and Vitamin B12   
E. Applicant: Roche Diagnostics   
F. Proprietary and Established Names: Elecsys $^ \mathrm { \textregistered }$ PreciControl Anemia

# G. Regulatory Information:

1. Regulation section: 21 CFR §862.1660 Quality control material (assayed and unassayed)

2. Classification: Class I

3. Product code: JJX

4. Panel: 75 – Clinical Chemistry

# H. Intended Use:

1. Intended use: See Indications for use below.

2. Indications for use:

Elecsys $^ \mathrm { \textregistered }$ PreciControl Anemia is used for quality control of the Elecsys $^ \mathrm { \textregistered }$ Ferritin, Folate II, and Vitamin B12 immunoassays on the Elecsys $^ \mathrm { \textregistered }$ immunoassay systems.

3. Special conditions for use statement: N/A

4. Special instrument requirements: Elecsys $^ \mathrm { \textregistered }$ immunoassay systems

# I. Device Description:

The Elecsys $^ \mathrm { \textregistered }$ PreciControl Anemia is a lyophilized product consisting of added ferritin and aprotinine in human serum matrix. During manufacture, the analytes are spiked into the matrix at the desired concentrations.

# J. Substantial Equivalence Information:

1. Predicate device name: Elecsys $^ \mathrm { \textregistered }$ PreciControl MultiAnalyte

2. Predicate 510(k) number: k033937

3. Comparison with predicate:

<table><tr><td colspan="3" rowspan="1">Similarities</td></tr><tr><td colspan="1" rowspan="1">Characteristic</td><td colspan="1" rowspan="1">Elecsys PreciControl Anemia</td><td colspan="1" rowspan="1">Predicate device - ElecsysPreciControl MultiAnalyte</td></tr><tr><td colspan="1" rowspan="1">Intended Use</td><td colspan="1" rowspan="1">Elecsys? PreciControl Anemiais used for quality control ofthe Elecsys? Ferritin, FolateII, and Vitamin B12immunoassays on theElecsys? immunoassaysystems.</td><td colspan="1" rowspan="1">Elecsys? PreciControlMultiAnalyte is used forquality control of the Elecsys?C-Peptide and Elecsys?Insulin immunoassays on theElecsys? immunoassaysystems.</td></tr><tr><td colspan="1" rowspan="1">Levels</td><td colspan="1" rowspan="1">Three</td><td colspan="1" rowspan="1">Two</td></tr><tr><td colspan="1" rowspan="1">Format</td><td colspan="1" rowspan="1">Lyophilized</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Handling</td><td colspan="1" rowspan="1">Reconstitute with exactly 2.0mL distilled water and allow tostand closed for 30 minutes toreconstitute, and then mixgently.</td><td colspan="1" rowspan="1">Reconstitute with exactly 2.0 mL distilled water and allow tostand closed for 15 minutes toreconstitute, and then mixgently.</td></tr><tr><td colspan="1" rowspan="1">Characteristic</td><td colspan="1" rowspan="1">Elecsys PreciControl Anemia</td><td colspan="1" rowspan="1">Predicate device - Elecsys PreciControl MultiAnalyte</td></tr><tr><td colspan="1" rowspan="1">Stability</td><td colspan="1" rowspan="1">Unopened:Store at 2 - 8C until expirationdateReconstituted:·   20 - 25℃: up to 8 hours.  on the analyzers at 20 -25℃: up to 5 hours.  at 2-8℃: 3 days.  at -20℃:1 month(freeze only once)after thawing: use onlyonce</td><td colspan="1" rowspan="1">Unopened:Store at 2 - 8C until expirationdateReconstituted:.  on the analyzers at 20 -25℃: up to 3 hoursat -20℃: 1 month(freeze only once)after thawing: use onlyonce</td></tr></table>

<table><tr><td rowspan=1 colspan=3>Differences</td></tr><tr><td rowspan=1 colspan=1>Characteristic</td><td rowspan=1 colspan=1>Elecsys PreciControl Anemia</td><td rowspan=1 colspan=1>Predicate deviceElecsys PreciControlMultiAnalyte</td></tr><tr><td rowspan=1 colspan=1>Matrix</td><td rowspan=1 colspan=1>Human serum with addedFerritin (human origin) andAprotinine (bovine origin)</td><td rowspan=1 colspan=1>Equine serum with added C-Peptide and insulin</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

None referenced

L. Test Principle: Not applicable

# M. Performance Characteristics (if/when applicable):

1. Analytical performance: a. Precision/Reproducibility: N/A b. Linearity/assay reportable range: N/A c. Traceability, Stability, Expected values (controls, calibrators, or methods): Traceability: Roche Diagnostics maintains a set of master calibrators for each assay that have values assigned that are traceable to the various method “gold standards”. These standards can either be WHO, NIST or in-house developed standards. The Elecsys $^ \mathrm { \textregistered }$ PreciControl products are assayed and compared to these reference preparations and target values and ranges are assigned. Values are assigned using Elecsys $^ \mathrm { \textregistered }$ MODULAR ANALYTICS E170, Elecsys $^ \mathrm { \textregistered }$ 2010 and Elecsys $^ \mathrm { \textregistered }$ 1010 Immunoassay Analyzers. Two independent series of analyses are performed on each instrument for each analyte. Each sample is tested in duplicate. The target value is calculated as the median of the determined values.

Stability: Five studies were performed to verify the stability claims for Elecsys $^ \mathrm { \textregistered }$ PreciControl Anemia. The acceptance criterion for Ferritin and Vitamin B12 is recovery of $9 0 \% - 1 1 0 \%$ of the concentration based on unstressed material. The acceptance criterion for Folate II is for samples with concentrations of $\leq 5 ~ \mathrm { n g / m L }$ , a SD ${ \leq } 0 . 5 ~ \mathrm { { n g / m L } }$ and for concentrations ${ > } 5$ $\mathrm { { n g / m L } }$ is recovery of $+ / - 1 0 \%$ .

<table><tr><td rowspan=1 colspan=1>Stability</td><td rowspan=1 colspan=1>Unopened</td><td rowspan=1 colspan=1>Reconstituted</td></tr><tr><td rowspan=1 colspan=1>ElecsysPreciControlAnemia</td><td rowspan=1 colspan=1>Store at 2 - 8C untilexpiration date</td><td rowspan=1 colspan=1>020 - 25℃: up to8 hoursoon theanalyzersat 20 - 25℃: 1up to5 hoursoat 2-8℃: 3 daysoat -20℃: 1month (freezeonly once)oafter thawing:use only once</td></tr></table>

d. Detection limit: N/A e. Analytical specificity: N/A f. Assay cut-off: N/A

2. Comparison studies:

a. Method comparison with predicate device: N/A

b. Matrix comparison: N/A

3. Clinical studies:

a. Clinical Sensitivity: N/A

b. Clinical specificity: N/A   
c. Other clinical supportive data (when a. and b. are not applicable): N/A

4. Clinical cut-off:

N/A

5. Expected values/Reference range:

Lot specific target values for Elecsys $^ \mathrm { \textregistered }$ 2010 analyzer are presented in the following table:

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>PCAnemiaILow</td><td rowspan=1 colspan=1>PCAnemiaIIMedium</td><td rowspan=1 colspan=1>PCAnemiaⅢIHigh</td></tr><tr><td rowspan=1 colspan=1>FolateII(ng/mL)</td><td rowspan=1 colspan=1>2.89</td><td rowspan=1 colspan=1>7.74</td><td rowspan=1 colspan=1>16.2</td></tr><tr><td rowspan=1 colspan=1>Ferritin(ng/mL)</td><td rowspan=1 colspan=1>11.9</td><td rowspan=1 colspan=1>431</td><td rowspan=1 colspan=1>1320</td></tr><tr><td rowspan=1 colspan=1>VitaminB12(pg/mL)</td><td rowspan=1 colspan=1>287</td><td rowspan=1 colspan=1>773</td><td rowspan=1 colspan=1>1610</td></tr></table>

# N. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.